Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
alemtuzumab (campath) (1 trial)
Lymphoma (Phase 2)
Waldenstrom Macroglobulinemia (Phase 2)
Trials (1 total)
Trial APIs (1 total)